Antidiabetic drugs

March 2003    Volume 10, Issue 2   Br J Cardiol 2003;10:128-36

Authors:
Clifford J Bailey, Caroline Day

Achieving good glycaemic control is an important part of the treatment strategy to minimise vascular complications in diabetes. An expanding range of differently acting oral antidiabetic agents provides new choices for type 2 patients. This review considers the attributes and limitations of these agents, and their positioning in the treatment process.

back to top

Comments

There are currently no comments for this article - leave a comment

You must be logged in to post a comment.
Not yet a member? Register now for free.

back to top